| Year | Department | Item(s) | Cost |
|
2006 |
Arts In Medicine |
Artists in Residence |
$20,000.00 |
|
2006 |
Child Life |
Child Life Program Support materials |
$6,000.00 |
|
2006 |
Food and Nutrition |
Kids' Meals |
$4,000.00 |
|
2006 |
Operating Room |
Operating Room Tours |
$2,500.00 |
|
2006 |
Patient and Family Resources |
Chronically Ill Children's and Families' Assistance Fund |
$10,000.00 |
|
2006 |
Shands Children's Hospital |
Aquariums |
$900.00 |
|
2006 |
Shands Children's Hospital |
Laundry Detergent |
$1,000.00 |
|
2006 |
Shands Children's Hospital |
Food Program |
$40,000.00 |
|
2006 |
Shands Children's Hospital |
SCH Family Advisory Committee Refreshments |
$750.00 |
|
2006 |
Shands Children's Hospital |
SCH Family Resource Room Supplies |
$1,000.00 |
|
2006 |
Shands Children's Hospital |
Parking Program |
$15,000.00 |
|
2006 |
Rehab Services/Burn Care |
Burn Garments |
$15,000.00 |
|
2006 |
Shands Children's Hospital |
Guest Services Program |
$186,907.00 |
|
2006 |
Shands Children's Hospital |
Curtains for the Shands AGH |
$120,000.00 |
|
2006 |
Shands Children's Hospital |
Renovation of 9 bed IMC renovation |
$460,800.00 |
|
2006 |
Shands Children's Hospital |
Honorarium for Children's Hospital |
$1,000.00 |
|
2006 |
Shands Children's Hospital |
Diversion activities |
$25,000.00 |
|
2006 |
Child Life |
Child Life Program - (hospital and clinic staff) |
$138,000.00 |
|
2006 |
Hospital |
Pediatric Safety Award ($6,000/yearx3) |
$6,000.00 |
|
2006 |
Affiliation |
FSU College of Medicine Pediatric Program |
$135,876.90 |
|
2006 |
Child Life Clinics |
Out-patient Child Life Program |
$6,000.00 |
|
2006 |
Patient and Family Resources |
Pediatric Resouce Materials |
$6,000.00 |
|
2006 |
Community Relations |
Safe Kids Program |
$200,000.00 |
|
2006 |
Department of Pediatrics |
DJB Fellowship Award |
$103,000.00 |
|
2006 |
Pediatric Surgery |
Surgery research |
$103,000.00 |
|
2006 |
Genetics |
Dr. Thomas Dennis awarded funds for research start-up in the area of molecular cytogenetics. Specific projects included the development of techniques to determine the safety of gene therapy for genetic diseases, such as glycogen storage disease, alpha-1 ="MM_swapImgRestore();status=' |
$157,990.00 |
|
2006 |
Neonatology |
Dr. Matthew Saxonhouse awarded funding in support of his research on the function of platelets and other aspects of blood clotting in newborn infants. The propensity of premature newborns to bleed into their brains and in other organs is a major source o="MM_swapImgRestore();status=' |
$53,340.00 |
|
|
DEPARTMENT |
ITEM(S) |
|
|
2006 |
Hematology/Oncology |
Dr. William Slayton awarded funds for research in the basic biology of bone marrow stem cells. These stem cells play a central role in the use of bone marrow transplantation as therapy for children with many forms of cancer |
$4,067.00 |
|
2006 |
Immunology, Rheumatology, and Infectious Diseases |
Dr. Melissa Elder awarded research funding for her work on gene therapy for severe combined immune deficiency (SCID). |
$61,840.00 |
|
2006 |
Nephrology |
Dr. Robert Fennell received funding to support the kidney transplant program. This is the most active transplant program in children at Shands&UF, and children treated in this program are able to come off kidney dialysis permanently, if the treatment is ="MM_swapIm |
$330.00 |
|
2006 |
Neurology |
Dr. Ann-Marie Slinger-Constant awarded funding for her clinical research in her clinic for children with school problems. Dr. Slinger is examining neurologic structure and function and testing the long-term benefits of certain interventions in children w="MM_swapImgRestore(); |
$44,426.00 |
|
2006 |
Endocrinology |
Dr. Jennifer Miller awarded funding for her work on extreme forms of obesity in young children, including children with a genetic cause of obesity, the Prader-Willi Syndrome (PWS), and a newly identified early-childhood morbid obesity (EMO) syndrome, whic="MM_swapImgRestore();status=' |
$89,949.00 |
|
2006 |
Nephrology |
Dr. Eduardo Garin awarded funding for his cutting edge research on immune dysregulation in children with minimal change nephrotic syndrome, as well as for another project on vesico-ureteral reflux. |
$138,732.00 |
|
2006 |
Critical Care Medicine |
Dr. Ann Marie Levine awarded funding for her work on genetic contributors to host defense and immune regulation in the lung. This work is relevant to premature and term infants and children who develop severe respiratory tract infections, such as pneumon="MM_swapImgRestore() |
$273,414.00 |
|
2006 |
Endocrinology |
Dr. Milagros Huerta awarded funding for her work on children with type 2 diabetes and obesity, particularly studying inflammatory mediators that might contribute to long-term cardiovascular complications in these children. |
$185.00 |
|
2006 |
Critical Care Medicine |
Dr. Ikram Haque awarded funding for supplies required in his research on brain circulation and other aspects of resuscitation and life support in infants and children. |
$723.00 |
|
2006 |
Neurology |
Dr. Richard Frye awarded funding for his work on innovative imaging studies on normal children and children with neurologic diseases. |
$1,414.00 |
|
2006 |
Neurology |
Dr. Zhao Liu awarded funding for his research in the area of pediatric epilepsy. His work includes brain-machine interface technology for the prediction and prevention of epileptic seizures. Other work includes pioneering studies of gene therapy for epil="MM_ |
$36,848.00 |
|
|
DEPARTMENT |
ITEM(S) |
|
|
2006 |
Cellular and Molecular Therapy |
Dr. Arun Srivastava awarded funding for gene and stem cell therapy for diseases of the bone marrow, such as sickle cell anemia and thalassemia. This work could allow for the first definitive treatment for these diseases |
$104,338.00 |
|
2006 |
Cellular and Molecular Therapy |
Dr. Kenneth Warrington awarded funding for gene therapy of diseases of the brain, in particular brain tumors. His work could allow for the development of treatments for children who currently have an incurable form of cancer. |
$20,983.00 |
|
2006 |
Cellular and Molecular Therapy |
Dr. Kirsten Weigel-Kellyawarded funding for the development of new gene transfer agents that might be used to treat diseases of the bone marrow. This new class of gene transfer agents is based on a parvovirus and is completely unique to her work. |
$11,421.00 |
|
|
Total |
|
$2,607,733.90 |
|
|
|
|
|
